NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026
Estimated value
—
Awarded value
£201.7m
Awarded 14 Jun 2026
Suppliers
27
6 SME
Lots
2
2 awarded
Published
23 Jun 2026
Total lots
2
Awarded
2
0 pending
Estimated total
£877.7m
Awarded total
£201.7m
Lot 1complete
CM/PHR/25/5730/01 - Tranche B for NOFE and MAE
Award value
£166.3m
Start
31 Aug 2026
End
31 Aug 2028
Estimated
£846.1m
CPV
33600000
Awarded to 25 suppliers
BP
CH 00935048
NN
CH 01118740
Lot 2complete
CM/PHR/25/5730/02 - Natalizumab for London & SOFE
Award value
£35.3m
Start
31 Aug 2026
End
31 Aug 2027
Estimated
£31.5m
CPV
33600000